Quartet Medicine's Series A - II Round

Quartet Medicine raised a round of funding on October 07, 2015. Investors include Remeditex Ventures.

Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data poi…

Articles about Quartet Medicine's Series A - II Round: